The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-chloro-3-(trifluoromethyl)phenyl)-4-(3,5-dimethyl-1H-pyrazol-1-yl)-6-hydrazinyl-1,3,5-triazin-2-amine ID: ALA4514227
PubChem CID: 155539218
Max Phase: Preclinical
Molecular Formula: C15H14ClF3N8
Molecular Weight: 398.78
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)n(-c2nc(NN)nc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)n1
Standard InChI: InChI=1S/C15H14ClF3N8/c1-7-5-8(2)27(26-7)14-23-12(22-13(24-14)25-20)21-9-3-4-11(16)10(6-9)15(17,18)19/h3-6H,20H2,1-2H3,(H2,21,22,23,24,25)
Standard InChI Key: CBURLVUZHNXWGR-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
8.3191 -17.8172 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3179 -18.6367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0260 -19.0457 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7356 -18.6363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7328 -17.8136 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0242 -17.4083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6126 -19.0480 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8663 -18.7151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3190 -19.3220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7271 -20.0301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5265 -19.8607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4440 -19.0438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4453 -19.8609 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0217 -16.5912 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7282 -16.1805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4351 -16.5893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1411 -16.1793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1391 -15.3612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4252 -14.9549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7221 -15.3673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8450 -14.9496 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.8498 -16.5861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8518 -17.4033 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.5565 -16.1757 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.5550 -16.9918 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.1334 -20.4079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5064 -19.2359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 7 1 0
2 7 1 0
4 12 1 0
12 13 1 0
6 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
17 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
11 26 1 0
9 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.78Molecular Weight (Monoisotopic): 398.0982AlogP: 3.38#Rotatable Bonds: 4Polar Surface Area: 106.57Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.17CX Basic pKa: 8.48CX LogP: 4.62CX LogD: 3.56Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.46Np Likeness Score: -2.43
References 1. Wang L, Jiang J, Zhang L, Zhang Q, Zhou J, Li L, Xu X, You Q.. (2020) Discovery and Optimization of Small Molecules Targeting the Protein-Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer., 63 (3): [PMID:31935086 ] [10.1021/acs.jmedchem.9b01659 ]